Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and…

By B. Howden, John K. Davies, Paul D R Johnson, T. Stinear, M. Grayson. Clinical Microbiology Reviews, 2010

961 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/2e63c34ab4b7b3faa1251fdaf09f15dfaf5688fd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. G. Peters
2. T. Foster
3. K. Becker
4. Christine Heilmann

In Molecular Biology

1. G. Peters
2. T. Foster
3. K. Becker
4. Christine Heilmann

Citations in the corpus

• Antibiotic resistance in Staphylococcus aureus. Current status and future prospects (2017, background): “In general, it is believed that the initial step occurs in one of several global regulators that directly or indirectly alter cell wall biosynthesis and cell physiology (Howden et al. 2010; Gardete and Tomasz 2014; Howden, Peleg and Stinear 2014; Zeng et al. 2016).”
• Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus (2020, background): “Subsequently, the United States, China and other places have successively discovered multiple VISA (Howden et al., 2010).”
• Coagulase-Negative Staphylococci (2014, background): “aureus, including antibiotic-containing agar media and specialized gradient tests (macro-Etest) (508).”
• Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management (2015, neutral): “With diabetes 110 (20) 35 (13) 2 (6) 19 (26) 12 (20) 8 (30)”